Gujarat Kidney and Super Speciality Quarterly Results for Trading Insights
In Mar 2026, Gujarat Kidney and Super Speciality (GKSL) reported revenue ₹31 Cr and net profit ₹5 Cr — revenue +210.0% YoY. Also explore GKSL price movement history to track price trends across different timeframes.
GKSL Quarterly Results — Revenue, Profit & EPS Highlights
Gujarat Kidney and Super Speciality latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Gujarat Kidney and Super Speci screener.
- Revenue of ₹31 Cr in Mar 2026 (+138.5% vs Sept 2025, +210.0% vs Mar 2025)
- Net Profit of ₹5 Cr in Mar 2026 (+66.7% vs Sept 2025, +400.0% vs Mar 2025)
- EBITDA of ₹7 Cr in Mar 2026 (+40.0% vs Sept 2025)
- Operating Margin of 21.0% in Mar 2026 (-19.0pp vs Sept 2025)
- Earnings Per Share of ₹0.81 in Mar 2026 (+72.3% vs Sept 2025)
Gujarat Kidney and Super Speciality Quarterly Results — Revenue, EBITDA, Net Profit & EPS
GKSL quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 31 | 13 | 10 | 15 | 23 | 138.5% | 210.0% |
| Net Profit (₹ Cr) | 5 | 3 | 1 | 5 | 4 | - | - |
| EBITDA (₹ Cr) | 7 | 5 | 3 | 9 | 7 | - | - |
| EPS (₹) | 0.81 | 0.47 | 0.25 | 0.85 | 0.52 | - | - |
| Operating Margin (%) | 21.0% | 40.0% | 27.0% | 57.0% | 30.0% | - | - |
GKSL Share Price Trend — 1-Year Movement Across Quarterly Results
Gujarat Kidney and Super Speciality 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Browse GKSL complete financial statements for revenue, profit, balance sheet and cash flow data.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
GKSL vs Healthcare Services Peers — Quarterly Revenue, Profit & Market Cap
Gujarat Kidney and Super Speciality latest quarter revenue and net profit vs Healthcare Services competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Apollo Hospitals
Mar 2026 |
₹127,874.88 Cr | 8893.5 | 6,660 | 551 | +4.6% | +17.6% | 8.3% | 241.5 |
|
Max Healthcare Inst…
Mar 2026 |
₹109,903.55 Cr | 1153.4 | 2,191 | 342 | +1.1% | +12.0% | 15.6% | 327.7 |
|
Fortis Healthcare
Mar 2026 |
₹71,751.22 Cr | 974.6 | 2,375 | 271 | -0.3% | +16.9% | 11.4% | 276.9 |
|
Aster DM Healthcare
Mar 2026 |
₹40,644.00 Cr | 793.2 | 1,219 | 154 | -0.6% | +18.1% | 12.6% | 291.6 |
|
Narayana Hrudayalaya
Mar 2026 |
₹40,398.04 Cr | 2002.8 | 2,623 | 224 | +57.3% | +74.5% | 8.5% | 181.7 |
All amounts in ₹ Crores